en
Scientific article
Review
English

The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma

Published inEuropean Journal of Cancer, vol. 112, p. 1-8
Publication date2019
Abstract

Multimodal primary treatment of localised adenocarcinoma of the stomach, the oesophagus and the oesophagogastric junction (AEG) was reviewed by a multidisciplinary expert panel in a moderated consensus session. Here, we report the key points of the discussion and the resulting recommendations. The exact definition of the tumour location and extent by white light endoscopy in conjunction with computed tomography scans is the backbone for any treatment decision. Their value is limited with respect to the infiltration depth, lymph node involvement and peritoneal involvement. Additional endoscopic ultrasound was recommended mainly for tumours of the lower oesophagogastric junction (i.e. AEG type II and III according to Siewert) and in early cancers before endoscopic resection. Laparoscopy to diagnose peritoneal involvement was thought to be necessary before the start of neoadjuvant treatment in all gastric cancers and in AEG type II and III. In general, perioperative multimodal treatment was suggested for all locally advanced oesophageal tumours and for gastric cancers with a clinical stage above T1N0. There was consensus that the combination of fluorouracil, folinic acid, oxaliplatin and docetaxel is now a new standard chemotherapy (CTx) regimen for fit patients. In contrast, the optimal choice of perioperative CTx versus neoadjuvant radiochemotherapy (neoRCTx), especially for AEG, was identified as an open question. Expert treatment recommendations depend on the tumour location, biology, the risk of incomplete (R1) resection, response to treatment, local or systemic recurrence risks, the predicted perioperative morbidity and patients' comorbidities. In summary, any treatment decision requires an interdisciplinary discussion in a comprehensive multidisciplinary setting.

Keywords
  • Adenocarcinoma of the gastro-oesophageal junction
  • Expert consensus
  • Gastric cancer
  • Multimodal treatment
Citation (ISO format)
LUTZ, Manfred P et al. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. In: European Journal of Cancer, 2019, vol. 112, p. 1–8. doi: 10.1016/j.ejca.2019.01.106
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0959-8049
194views
1downloads

Technical informations

Creation09/16/2019 8:39:00 AM
First validation09/16/2019 8:39:00 AM
Update time03/15/2023 9:29:14 PM
Status update03/15/2023 9:29:11 PM
Last indexation01/17/2024 9:35:37 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack